+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Fibrates"

Fibrate Drugs Global Market Report 2024 - Product Thumbnail Image

Fibrate Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
Atherosclerosis Drugs Global Market Report 2024 - Product Thumbnail Image

Atherosclerosis Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
From
From
From
Disease Analysis: Dyslipidemia - Product Thumbnail Image

Disease Analysis: Dyslipidemia

  • Report
  • November 2020
  • 101 Pages
  • Global
From
Dyslipidemia Market Report and Forecast 2024-2032 - Product Thumbnail Image

Dyslipidemia Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
  • 15 Results (Page 1 of 1)
Loading Indicator

Fibrates are a class of drugs used to treat cardiovascular diseases, such as high cholesterol and triglyceride levels. They work by increasing the activity of the enzyme lipoprotein lipase, which helps to break down fats in the blood. Fibrates are often used in combination with statins, another class of drugs used to lower cholesterol levels. Fibrates are generally well tolerated, but can cause side effects such as muscle pain, nausea, and abdominal pain. Fibrates are available in both prescription and over-the-counter forms. Commonly prescribed fibrates include fenofibrate, gemfibrozil, and clofibrate. Over-the-counter fibrates include omega-3 fatty acids, which are found in fish oil supplements. Several companies are involved in the fibrates market, including Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more